November 2024

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online
PBTI invites applications for post of Research Fellow - Salary Rs. 40,000 pm
1st class Masters Degree in Biotechnology, Chemistry, Biochemistry, Food Science from a recognized University OR 1st class B. Tech Degree in Biotechnology, Food Technology from a recognized University
Vacancy for Junior Research Fellow at ACTREC
To work on project in Translational Research Laboratory Area of research DNA damage repair and cancer. M.Sc. degree obtained after a one-year course will not be considered.
Central University of Punjab Admission to PhD Program 2024-25 Academic Session
B.Pharmacy degree and Master degree M.Pharm, M.S Pharm, M.Sc. Pharmacology or equivalent with minimum of 55% marks
Vacancy for M.Pharm, B.Pharm, MSc in Commercial Operations Department at JAMP Pharma group
Ensure projects are kicked off appropriately and required information defining the scope of the project is properly identified. Ensure that a project schedule encompassing project scope and associated details is accurately developed and regularly maintained.
Walk In Drive for M.Pharm, B.Pharm, MSc in QA, QC, Production at Macleods Pharmaceuticals
2-8 years of experience in BMR, QMS, PQR, Qualification, AQA, ERP, Control Sample, Process Validation.
Lupin Limited Walk in drive at Ahmedabad for B.Pharm, MSc in QC Department
Analyst worked in AMT, AMV section having exposure to HPLC, GC, IC, AAS. Analyst worked in GLP Section having exposure instrument calibration, Qualification, Standard Management, Working Standard qualification.
New study reveals genetic drivers of early onset type 2 diabetes in South Asians 

The findings, published today in Nature Medicine, show that these genetic factors also lead to quicker development of health complications, earlier need for insulin treatment, and a weaker response to some medications. The results of this research, funded by Barts Charity and Wellcome, reinforce the need to understand how genetic variation across different population groups can influence the onset of diseases, treatment responses, and disease progression. 

Dr. Reddy's launches Toripalimab in India
Toripalimab is a New Biological Entity. It is the only immuno-oncology drug approved by various regulatory authorities around the world such as the United States Food and Drug Administration, European Medicines Agency, Medicines and Healthcare products Regulatory Agency, and others for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma.
Study Details How Cancer Cells Fend Off Starvation & Death from Chemotherapy

Laboratory experiments with cancer cells reveal two ways in which tumors evade drugs designed to starve and kill them, a new study shows.

Abbott launches 14 valent Pneumococcal Conjugate Vaccine (PCV-14) That Offers Broadest Protection for Children Against Pneumococcal Bacterial Infections

Abbott, the global healthcare leader, announced today the launch of its Pneumococcal Conjugate Vaccine, PneumoShield 14, for children over 6 weeks of age. Abbott’s PCV-14 valent (Pneumococcal Conjugate Vaccine), offers broad protection, covering the highest number of serotypes, or strains, as compared to existing PCV-10 and PCV-13 vaccines.